glp-1 news october 9 2025 Ozempic Pitfalls and Natural Weight Balance | The American Chiropractor glp-1 news october 9 2025

Shima Hadidchi, MD, in Apple Valley and Victorville, CA

Eli Lilly reported another success in a study pitting its once-daily oral GLP-1 therapy Orforglipron against a competing type 2 DM therapy, this time AstraZeneca's SGLT2I Farxiga (Dapagliflozin)

Shop music, movies, toys & games, too

From a scientific breakthrough studying the oft fasting Gila Monster has become the current successful weight loss therapies, here's how.

In this Evidence-based guideline, the authors use a Delphi consensus process to develop uniform guidance for the definition, diagnosis and management of dumping syndrome.

Compare GLP-1 and GLP-3 peptides